Petersen RC, Smith GE, Warung SC e.a. Mild cognitive impairment. Clinical characterization and outcome. Arch Neurol 1999; 56:303-308.
Unverzagt FW, Gao S, Baiyewu O e.a. Prevalence of cognitive impairment. Data from the Indianapolis Study of Health and Aging. Neurology 2001; 57: 1655-1662
Lopez OL, Jagust WJ, DeKosky ST e.a. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study (CHS): Cognition Study. Arch Neurol 2003a; 60:1385-1389
Dik MG. Cognitive decline in older persons. Contribution of genetics, health and lifestyle. Thesis, VU Medisch Centrum 2002, Amsterdam
Lopez OL, Jagust WJ, Dulberg C e.a. Riskfactors for mild cognitive impairment in the cardiovascular Health Study (CHS): Cognition Study. Arch Neurol 2003b; 60:1394-1399
Kral VA. Senescent forgetfulness: benign and malignant. J Can Med Assoc 1962; 86:257-260
Crook T, Bartus RT, Ferris SH e.a. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Work Group. Developmental Neuropsychology 1986; 2:261-276
Levy R. Aging-associated cognitive decline. Int Psychogeriatrics 1994; 6:63-68
Richards M, Touchon J, Ledésert B e.a. Cognitive decline in ageing: are AAMI and AACD distinct entities? Int J Geriatr Psychiatry 1999; 14:534-540
Graham JE, Rockwood K, B Lynn Beattie e.a. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349:1793-1796
Rubin EH, Kinscherf D. Psychopathology of very mild dementia of the Alzheimertype. Am J Psychiatry 1989; 146:1017-1021
Zaudig M A. new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-IIIR criteria. Int Psychogeriatr 1992; suppl 2:203-219.
Petersen RC, Doody R, Kurz A e.a. Current concepts in Mild Cognitive Impairment. Arch Neurol 2001; 58:1985-1992.
Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004; 256:183-194
Visser PJ, Scheltens P, Verhey FRJ. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? J Neurol Neurosurg Psychiatry 2005; 76:1348-1354
Schmand B, Jonker C, Hooijer C e.a. Subjective memory complaints may announce dementia. Neurology 1996; 46:121-125.
Bowen J, Teri L, Kukull W e.a. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349:763-765
Hodges J. The amnestic prodrome of Alzheimer's disease. Brain 1998; 121:1601-1602
Ritchie K & Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000; 355:225-228
Daly E, Zaitchik D, Copeland M e.a. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol 2000; 57:675-680
Chen P, Ratcliff D, Belle SH e.a. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55:1847-1853
Wang QS & Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Research 2002; 924:113-115
Berg L, Hughes CP, Danziger WL e.a. Mild senile dementia of Alzheimertype (SDAT): research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatr 1982; 45:962-968
Ritchie K Artero S, Touchon J. Classification criteria for mild cognitive impairment. A population-based validation study. Neurology 2001; 56:37-42
McKelvey R, Bergman H, Stern J. Lack of prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss. Can J Neurol 1999; Sci 26:23-28
Bennett DA, Wilson RS, Schneider JA. e.a. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59:198-205
Morris JC, Storandt M, Miller JP e.a. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58:397-405
Tabert MH, Albert SM, Borukhova-Milov L e.a. Functional deficits in patients with mild cognitive impairment. Neurology 2002; 58:758-764
Larrieu S, Letteneur L, Orgogozo JM. e.a. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002; 59:1594-1599
Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003; 61:1179-1184
Ganguli M, Dodge HH, Shen C e.a. Mild cognitive impairment, amnestic type. An epidemiologic study. Neurology 2004; 63:115-121
Comijs HC, Dik MG, Deeg DJH, e.a. The course of cognitive decline in older persons: results from the Longitudinal Aging Study Amsterdam. Dement Geriatr Cogn Disord 2004; 17:136-142
Petry S, Cummings JL, Hill MA e.a. Personality alterations in dementia of the Alzheimer type. A three-year follow-up study. J Geriatr Psychiatry Neurology 1989; 2:203-207
Cummings JL, Mega M, Gray K e.a. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314
Lyketsos CG, Lopez O, Jones B e.a. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. JAMA 2002; 288:1475-1483.
Hwang TJ, Masterman DL, Ortiz F e.a. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alz Dis Assoc Disord 2004; 18 :17-21
Feldman H, Scheltens P, Scarpini E e.a. Behavioral symptoms in mild cognitive impairment. Neurology 2004; 62:1199-1201
Geerlings MI, Schoevers RA, Beekman ATF e.a. Depression and the risk of cognitive decline and Alzheimer's disease. Br J Psychiat 2000; 176, 568-575.
Ready RE, Ott BR, Grace J. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 2003; 11:222-228
Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type. A prospective cohort study. Arch Neurol 2004; 61:1290-1293
Tierney MC, Boyle E, Lam E. e.a. Do depressive symptoms in memory-impaired elders predict probable Alzheimer’s disease? Aging & Mental Health 1999; 3:88-93
Jack CR, Petersen RC, Xu YC e.a. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52:1397-1403
Blennow K & Hampel H. CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2003; 2:605-613
Arai H, Nakagawa T, Kosaka T e.a. Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals. Alzheimer’s Res 1997; 3:211-213.
Amieva H, Letteneur L, Dartiques JF e.a. Annual rate and predictors of conversion to dementia in subjects presenting with mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 2004; 18:87-93
Aggarwal NT, Wilson RS, Beck TL e.a. The apolipoprotein E epsilon4 allele and incident Alzheimer’s disease in persons with mild cognitive impairment. Neurocase 2005; 11:3-7
Kryscio RJ, Schmitt FA, Salazar JC e.a. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006; 66:828-832
Visser PJ, Verhey FRJ, Scheltens P e.a. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. J Neurol 2002; 249:312-319.
Petersen RC, Thomas RG, Grundman M e.a. Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine 2005; 352:2379-2388
Comijs HC, Deeg DJH, Dik MG e.a. Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. J Affective Disord 2002; 72:157-165
Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004; 3:343-353